Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Laser Hair Removal with Alexandrite versus Diode Laser Using Four Treatment Sessions: 1-Year Results



BACKGROUND Laser hair removal is the treatment of choice for hypertrichosis. The two most commonly used hair removal lasers are compared.

OBJECTIVE To present the results of a comparative study examining the role of wavelength, fluence, spot size, pulse width, and cooling systems on long-term results after a series of four laser hair removal treatments using the 755 nm alexandrite and 800–810 nm diode lasers.

METHODS The axillae of 15 untanned, type I–V patients were treated side by side four times at 4- to 6-week intervals with a 755 nm, 3-msec pulse width, cryogen spray-equipped alexandrite laser and an 800 nm, variable pulse width, cooled sapphire window-equipped diode laser. Each patient was pretested and treated with the maximum fluence tolerated at the largest spot size available for each laser (12 mm round/113 mm2 for the alexandrite and 9 mm for the diode).

RESULTS Evaluations were done at 3, 6, 9, and 12 months after the last treatment. Twelve-month results with the alexandrite and diode lasers achieved 85% versus 84% hair reduction. The fact that tan avoidance was strictly followed permitted the use of relatively high fluences (25–30+ J/cm2) even in type IV patients. For most patients, four treatment sessions using high fluences (30–40 J/cm2) with relatively large spot sizes (12 mm round for the 755 nm alexandrite and 9 mm for the 800 nm diode) resulted in 12-month hair reductions in the 90% range.

CONCLUSION Both the alexandrite and diode lasers in this 12-month study produced excellent long-term hair reductions.

*Division of Dermatology, UCLA, Los Angeles, California

Brockton Cosmetic Surgery Center, Riverside, California

Beverly Hills, California

Address correspondence and reprint requests to: Sorin Eremia, MD, 4440 Brockton Ave., Suite 200, Riverside, CA 92501.

S. Eremia, MD, C. Li, DO, and N. Newman, MD have indicated no significant interest with commercial supporters.

© 2001 by the American Society for Dermatologic Surgery, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website